Medical Weight Loss Monitor – Panel 10 Tests

Medical Weight Loss Monitor – Panel 10 Tests $129 otheer lab $299 

Designed for patients using weight loss medications such as Ozempic®, Wegovy®, Zepbound®, or Tirzepatide, this lab panel offers foundational insights into the biological systems most responsible for fat loss, energy, and long-term weight maintenance. It supports safe treatment plans and helps clinicians fine-tune therapy based on individual hormone, inflammation, and metabolic markers. 

1. General Health Screening 

• Complete Blood Count (CBC): Evaluates red blood cells, white blood cells, and platelets to rule out anemia or infection. 
Why it matters: Fatigue, immune compromise, or nutrient deficiencies can derail weight loss. CBC ensures foundational wellness before initiating therapy. 

2–6. Hormonal Balance 

• DHEA-Sulfate: Assesses adrenal function. Low DHEA may indicate chronic stress or hormonal burnout—often seen in metabolic resistance. 
• Estradiol: Monitors estrogen balance. Both excess and deficiency can affect fat distribution and mood. 
• Testosterone (Total + Free): Vital for men and women. Low levels can lead to fatigue, reduced lean mass, and poor metabolic drive. 
• TSH (Thyroid Stimulating Hormone): A first-line screen for thyroid issues. Hypothyroidism is a common cause of resistant weight gain. 
• Free T3 and Free T4: Active thyroid hormones that regulate cellular metabolism and energy production. Tracking these ensures thyroid balance is optimized for fat loss. 

7–10. Cardiovascular and Inflammatory Markers 

• Lipid Panel with Ratios: Assesses total cholesterol, LDL, HDL, and triglycerides—important for baseline cardiovascular risk before medication use. 
• hs-CRP (High-Sensitivity C-Reactive Protein): A sensitive marker of inflammation. Elevated hs-CRP may indicate metabolic syndrome or chronic weight-related inflammation. 
• Homocysteine: Linked to cardiovascular risk and impaired detoxification. Elevated levels may signal methylation issues affecting metabolism. 
• PSA (Prostate-Specific Antigen) – Men only: Required before starting hormone-based therapies. Helps rule out underlying prostate inflammation or cancer risk. 

Why Is This Panel Important? 

This panel supports safe and strategic weight loss, especially for those using GLP-1 agonists or hormone therapies. It identifies hormone imbalances, thyroid dysfunction, chronic inflammation, or cardiovascular risks that could prevent progress. Armed with this information, clinicians can customize and adjust your program to maximize fat loss while preserving lean mass and energy. 

Who Should Consider This Panel? 

This panel is ideal for patients who: 
- Are initiating or currently using weight loss injections (Ozempic®, Wegovy®, Zepbound®, Mounjaro®) 
- Want baseline safety screening before starting a program 
- Suspect hormonal/metabolic blocks to weight loss 
- Are using testosterone or other hormone optimization strategies 
- Need progress tracking and plan adjustments during therapy